International Biotechnology Trust’s Radius Health, Inc. RDUS Stock Holding History

International Biotechnology Trust’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-17,000	Closed	-$342K	–	68
2019 Q4	$342K	Hold	17,000	–	–	0.12%	60
2019 Q3	$437K	Hold	17,000	–	–	0.2%	54
2019 Q2	$414K	Sell	17,000 -88,829	-84%	-$1.94M	0.15%	62
2019 Q1	$2.11M	Sell	105,829 -158,382	-60%	-$2.89M	0.78%	38
2018 Q4	$3.42M	Buy	264,211 +245,412	+1,305%	+$4.13M	2.12%	18
2018 Q3	$257K	Hold	18,799	–	–	0.12%	50
2018 Q2	$554K	Hold	18,799	–	–	0.21%	53
2018 Q1	$675K	Hold	18,799	–	–	0.26%	61
2017 Q4	$597K	Hold	18,799	–	–	0.21%	62
2017 Q3	$725K	Sell	18,799 -96,000	-84%	-$3.77M	0.28%	51
2017 Q2	$5.19M	Buy	114,799 +95,000	+480%	+$3.63M	1.97%	14
2017 Q1	$765K	Hold	19,799	–	–	0.29%	55
2016 Q4	$753K	Buy	+19,799	New	+$942K	0.34%	41

Other funds holding RDUS

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

International Biotechnology Trust's RDUS Position: Q1 2020 in Review

International Biotechnology Trust sold out of Radius Health, Inc. (RDUS) in Q1 2020, closing a stake of 17,000 shares — an estimated $342K sold.

International Biotechnology Trust first reported a position in RDUS in Q4 2016 and held it in 13 quarters. The position peaked at $5.19M in Q2 2017. 142 funds tracked by Wall St. Rank hold RDUS as of Q1 2020.

International Biotechnology Trust reported no remaining Radius Health, Inc. position as of Q1 2020 after selling out during the quarter.
International Biotechnology Trust sold 17,000 Radius Health, Inc. shares in Q1 2020, an estimated $342K.
International Biotechnology Trust first reported a position in Radius Health, Inc. in Q4 2016 and held it in 13 quarters.
International Biotechnology Trust's Radius Health, Inc. position peaked at $5.19M in Q2 2017.
142 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.